Eloralintide
Late stageSynthetic peptide analogue
Research material. Not for human or animal consumption.
Research overview
Eloralintide (LY3841136) is an investigational amylin receptor agonist developed by Eli Lilly for once-weekly dosing in clinical trials. Amylin is co-secreted with insulin and slows gastric emptying and signals satiety, so amylin analogues are being studied alongside incretin drugs for obesity. Preclinical assays describe preferential activity at the human AMY1 receptor. A Phase 1/2 study reported dose-dependent weight reduction, and a Phase 3 programme is now registered in obesity with and without type 2 diabetes.
Substantial controlled clinical research or late stage development has been identified; this is not a product authorisation claim.
Questions about Eloralintide
PRODUCT QUESTIONSWhat is Eloralintide?
Eloralintide is a synthetic peptide analogue used in metabolic research and referenced in obesity development literature.
What research has been published on Eloralintide?
Eloralintide (LY3841136) is an investigational once weekly amylin receptor agonist, and preclinical assays show preferential activity at the human AMY1R receptor. Phase 1/2 work reported weight management signals, while registry listed Phase 3 studies evaluate obesity in populations with and without type 2 diabetes and in obesity related contexts including obstructive sleep apnoea and knee osteoarthritis. It is not authorised for human clinical use.
What batch documentation should accompany Eloralintide?
Eloralintide: Ask for the COA and analytical reports for the batch being quoted. Because eloralintide is a lipidated amylin analogue, the report should confirm intact mass by mass spectrometry, show an HPLC purity trace that separates truncated and deacylated species, and state peptide content rather than gross powder weight.
How should Eloralintide storage conditions be assessed?
Eloralintide is supplied as a lyophilised solid. Keep it frozen at −20°C in a desiccated, light protected container and let the vial reach room temperature before opening. Amylin analogues are prone to aggregation in solution, so prepare solutions fresh and avoid repeated freeze and thaw cycles.
Request a quotation
Enquire about Eloralintide and the documentation for the available batch.
Request a quotation